These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24711009)

  • 1. Role of low-intensity laser therapy on naloxone-precipitated morphine withdrawal signs in mice: is nitric oxide a possible candidate mediator?
    Ojaghi R; Sohanaki H; Ghasemi T; Keshavarz F; Yousefifard M; Sadeghipour HR
    Lasers Med Sci; 2014 Sep; 29(5):1655-9. PubMed ID: 24711009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of morphine withdrawal signs by low level laser therapy in rats.
    Mirzaii-Dizgah I; Ojaghi R; Sadeghipour HR; Karimian SM; Sohanaki H
    Behav Brain Res; 2009 Jan; 196(2):268-70. PubMed ID: 18926854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
    Cappendijk SL; de Vries R; Dzoljic MR
    Neurosci Lett; 1993 Nov; 162(1-2):97-100. PubMed ID: 7510058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine suppresses morphine tolerance and dependence: modulation of NO-cGMP/DA/serotoninergic pathways.
    Singh VP; Jain NK; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2003 May; 25(4):273-80. PubMed ID: 12808472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice.
    Dambisya YM; Lee TL
    Br J Pharmacol; 1996 Mar; 117(5):914-8. PubMed ID: 8851510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine inhibits naloxone-precipitated morphine withdrawal symptoms: Role of inflammatory cytokines and nitric oxide.
    Mansouri MT; Naghizadeh B; Ghorbanzadeh B; Amirgholami N; Houshmand G; Alboghobeish S
    Metab Brain Dis; 2020 Feb; 35(2):305-313. PubMed ID: 31630319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
    Hall S; Milne B; Jhamandas K
    Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
    Buccafusco JJ; Terry AV; Shuster L
    Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester.
    Adams ML; Kalicki JM; Meyer ER; Cicero TJ
    Life Sci; 1993; 52(22):PL245-9. PubMed ID: 7684108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice.
    Majeed NH; Przewłocka B; Machelska H; Przewłocki R
    Neuropharmacology; 1994 Feb; 33(2):189-92. PubMed ID: 7518573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of simultaneous administration of alpha(2) -adrenergic agents with L-NAME or L-arginine on the development and expression of morphine dependence in mice.
    Zarrindast MR; Homayoun H; Khavandgar S; Fayaz-Dastgerdi M; Fayaz-Dastgerdi M
    Behav Pharmacol; 2002 Mar; 13(2):117-25. PubMed ID: 11981224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of opioidergic and nitrergic systems in memory acquisition and exploratory behaviors in cholestatic mice.
    Nasehi M; Piri M; Abbolhasani K; Zarrindast MR
    Behav Pharmacol; 2013 Jun; 24(3):180-94. PubMed ID: 23604167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice.
    Raghavendra V; Kulkarni SK
    Eur J Pharmacol; 2000 Dec; 409(3):279-89. PubMed ID: 11108822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
    Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
    Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase.
    Kimes AS; Vaupel DB; London ED
    Psychopharmacology (Berl); 1993; 112(4):521-4. PubMed ID: 7532866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cyclosporin A on morphine tolerance and dependence: involvement of L-arginine/nitric oxide pathway.
    Homayoun H; Khavandgar S; Namiranian K; Dehpour AR
    Eur J Pharmacol; 2002 Sep; 452(1):67-75. PubMed ID: 12323386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
    Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
    Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine.
    Vela G; Ruiz-Gayo M; Fuentes JA
    Neuropharmacology; 1995 Jun; 34(6):665-8. PubMed ID: 7566503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of FK506 on the development and expression of morphine tolerance and dependence in mice.
    Homayoun H; Khavandgar S; Mehr SE; Namiranian K; Dehpour AR
    Behav Pharmacol; 2003 Mar; 14(2):121-7. PubMed ID: 12658072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence.
    Naidu PS; Singh A; Joshi D; Kulkarni SK
    Addict Biol; 2003 Sep; 8(3):327-36. PubMed ID: 13129835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.